GLPGGalapagos N.V.

GLPG Stock Price, Valuation & Chart | Galapagos N.V.

Compare

$27.980+0.47 (+1.71%)

At close · 04 June 2026, 03:58 pm

Sector: Healthcare Industry: Biotechnology GLPG intrinsic value GLPG calculated fair value vs price

Overview Financials Dividends Ratios

GLPG Historical price chart

GLPG Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.84B

PE Ratio3.21

EPS8.71

Trading Volume2.38K

Today's High/Low28.09/27.5

Dividend Yield0.00

52 Week High/Low37.78/24.74

Shares Outstanding65.90M

GLPG Financial Statement

GLPG Analyst ratings

GLPG Analysis & performance metrics

GLPG Company profile

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its…

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD,…

GLPG Management team

Name

Position

Thad Huston C.M.A.CFO

Executive Vice President, Chief Financial Officer & Chief Operating Officer

Patrik Ringblom

Head of Strategy & US Lead

Ellen Van Der Aar

Head of Development

Pierre J.M.B. Raboisson Ph.D., Pharm.D.

Head of Small Molecules Discovery & Senior Vice President

Henry GosebruchCEO

Chief Executive Officer & Executive Director

Philippe Alen M.B.A., Ph.D., Pharm.D.

Senior Vice President & Head of Business Development

Alice Dietrich

Head of Medical Affairs

Marieke Vermeersch

Head of Corporate Communication

Name

Position

Thad Huston C.M.A.CFO

Executive Vice President, Chief Financial Officer & Chief Operating Officer

Patrik Ringblom

Head of Strategy & US Lead

Ellen Van Der Aar

Head of Development

Pierre J.M.B. Raboisson Ph.D., Pharm.D.

Head of Small Molecules Discovery & Senior Vice President

Henry GosebruchCEO

Chief Executive Officer & Executive Director

Philippe Alen M.B.A., Ph.D., Pharm.D.

Senior Vice President & Head of Business Development

Alice Dietrich

Head of Medical Affairs

Marieke Vermeersch

Head of Corporate Communication

Management Team

Thad Huston C.M.A.CFO

Executive Vice President, Chief Financial Officer & Chief Operating Officer

Patrik Ringblom

Head of Strategy & US Lead

Ellen Van Der Aar

Head of Development

Pierre J.M.B. Raboisson Ph.D., Pharm.D.

Head of Small Molecules Discovery & Senior Vice President

Henry GosebruchCEO

Chief Executive Officer & Executive Director

Philippe Alen M.B.A., Ph.D., Pharm.D.

Senior Vice President & Head of Business Development

Alice Dietrich

Head of Medical Affairs

Marieke Vermeersch

Head of Corporate Communication

Management

Thad Huston C.M.A.CFO

Executive Vice President, Chief Financial Officer & Chief Operating Officer

Patrik Ringblom

Head of Strategy & US Lead

Ellen Van Der Aar

Head of Development

Pierre J.M.B. Raboisson Ph.D., Pharm.D.

Head of Small Molecules Discovery & Senior Vice President

Henry GosebruchCEO

Chief Executive Officer & Executive Director

Philippe Alen M.B.A., Ph.D., Pharm.D.

Senior Vice President & Head of Business Development

Alice Dietrich

Head of Medical Affairs

Marieke Vermeersch

Head of Corporate Communication

Total 8 executives

GLPG Frequently asked questions

What is Galapagos N.V. (GLPG) Stock Price?

Current stock price of Galapagos N.V. (GLPG) stock is $27.980. The stock price is +1.71% higher in the session. The intraday range can be seen from this page. Volume of Galapagos N.V. (GLPG) stock is 2.38K.

Last updated at 04 June 2026, 03:58 pm.

Why is the Galapagos N.V. (GLPG) stock price going up or down today?

The stock price of Galapagos N.V. (GLPG) can change with earnings, company news, and overall market sentiment. Galapagos N.V. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Galapagos N.V. stock expensive at its current price?

Whether Galapagos N.V. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for GLPG on this page is 3.21. EPS on this page is 8.71. Compare those figures with peers and growth expectations before deciding if the current Galapagos N.V. price is justified.

How has the stock price of Galapagos N.V. (GLPG) performed historically?

Historical performance for Galapagos N.V. (GLPG) is shown on the price chart on this page. Review multi-period moves alongside volume to see how GLPG reacted to past earnings and market events.

Should I buy Galapagos N.V. (GLPG) stock, at this price?

Buying Galapagos N.V. (GLPG) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.